Stage 2 hypertension: predictors of failure to achieve blood pressure control and the impact of adding one additional antihypertensive class-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Stage 2 hypertension: predictors of failure to achieve blood pressure control and the impact of adding one additional antihypertensive class

Published:2015-09-09 Issue:11 Volume:24 Page:1170-1179
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Rowan Christopher G.¹²,Flory James³,Stempniewicz Nikita⁴,Cuddeback John⁴,Brunelli Steven M.⁵⁶

Affiliation:

1. Partnership for Health Analytic Research; Beverly Hills CA USA

2. Rutgers Biomedical and Health Sciences; Newark NJ USA

3. Weill Cornell Medical College; Department of Healthcare Policy and Research; New York New York USA

4. American Medical Group Association; Alexandria VA USA

5. DaVita Clinical Research; Minneapolis MN USA

6. DaVita HealthCare Partners; Denver CO USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference19 articles.

1. Hypertension as a risk factor for ischemic stroke in women;Gorgui;Can J Cardiol,2014

2. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people;Rapsomaniki;Lancet,2014

3. Systolic blood pressure, diastolic blood pressure, and pulse pressure: an evaluation of their joint effect on mortality;Pastor-Barriuso;Ann Intern Med,2003

4. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies;Lewington;Lancet,2002

5. Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population;Sim;J Am Coll Cardiol,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of Tengfu Jiangya tablet combined with valsartan/amlodipine in the treatment of stage 2 hypertension: study protocol for a randomized controlled trial;Trials;2022-02-22

2. Prescribing Patterns of Antihypertensive Agents and Blood Pressure Control Among Patients With Incident Stage 2 Hypertension;Journal of Pharmacy Technology;2022-01-26

3. Blood Pressure Visit Intensification in Treatment (BP-Visit) Findings: a Pragmatic Stepped Wedge Cluster Randomized Trial;Journal of General Internal Medicine;2021-08-11

4. Evaluation of a collaborative VA network initiative to reduce racial disparities in blood pressure control among veterans with severe hypertension;Healthcare;2021-06

5. Variation in the diagnosis and control of hypertension is not explained by conventional variables: Cross-sectional database study in English general practice;PLOS ONE;2019-01-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3